EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway

Manqian Zhou, Hui Wang, Zongjin Li

Clinical and Translational Discovery · 2022

DOI: 10.1002/ctd2.105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Discovery, 2022. Verfasst von Manqian Zhou und 2 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhou, M., Wang, H., & Li, Z. (2022). Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway. Clinical and Translational Discovery. https://doi.org/10.1002/ctd2.105

Vancouver

Zhou M, Wang H, Li Z. Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway. Clinical and Translational Discovery. 2022. doi:10.1002/ctd2.105

BibTeX
@article{Zhou2022,
  author = {Zhou, Manqian and Wang, Hui and Li, Zongjin},
  title = {Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway},
  journal = {Clinical and Translational Discovery},
  year = {2022},
  doi = {10.1002/ctd2.105}
}
Kostenlos starten →